Back to Market返回行情

SYK Stryker Corporation

USHealthcare
$328.72-0.31%OpenMarket Cap: $126.02B

As of 2026-07-08 11:42

Why SYK matters now

Stryker Corporation (SYK) is a US stock in Healthcare. The latest InvestLog snapshot shows $328.72 with -0.31% on the session and $126.02B in market capitalization; recent performance reads 1-month -3.13% and YTD -12.43%.

The latest financial table shown here is Q1 2026, with revenue of $6.02B, net income of $745.0M, and EPS of $1.93. Investors can compare that operating picture with valuation signals such as P/E 39.15 and FCF yield 3.9%.

The latest indexable market news headline is "Stryker: Medtech On Sale, Benefiting From Industry Growth" from Seeking Alpha.

Additional event context on this page matters because analyst consensus is Buy with a median target of $394.00; recent insider activity includes Stiles Spencer S filing G-Gift; recent congressional disclosure data includes Ro Khanna Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

39.15

PEG

4.63

P/B

5.13

P/S

4.67

EV/EBITDA

21.15

DCF Value

$334.96

FCF Yield

3.9%

Div Yield

1.1%

Margins & Returns

Gross Margin

63.7%

Operating Margin

21.3%

Net Margin

13.2%

ROE

15.1%

ROA

7.2%

ROIC

9.6%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$6.02B$745.0M$1.93
Q4 2025$7.17B$849.0M$2.20
FY 2025$25.12B$3.25B$8.40
Q3 2025$6.06B$859.0M$2.22

Analyst Ratings

Consensus

Buy

Target (Consensus)

$387.46

Target (Median)

$394.00

Target Range

$315.00 - $465.00

Strong Buy: 7Buy: 14Hold: 7Sell: 0Strong Sell: 0
Leerink PartnersOutperform
2026-06-05
BarclaysOverweight
2026-05-04
Truist SecuritiesHold
2026-05-04
JP MorganOverweight
2026-05-01
BTIGBuy
2026-05-01

Trading Activity

Insider Trades

Stiles Spencer Sofficer: President and COO
Sell2026-06-02
Fletcher Robert Sofficer: VP, Chief Legal Officer
Sell2026-05-29
Fletcher Robert Sofficer: VP, Chief Legal Officer
Sell2026-05-29
Fletcher Robert Sofficer: VP, Chief Legal Officer
Sell2026-05-29
Fletcher Robert Sofficer: VP, Chief Legal Officer
Sell2026-05-29

Congress Trades

Ro KhannaBuy
2026-05-13

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.79

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.